Rose Oil for Health & Longevity

Created on 11/01/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

Rose oil, a costly fragrant oil from Damask rose petals used in perfume, skin care and scent practices for wellbeing, is mostly inhaled. The most consistent human evidence points to short-lived calm: less anxiety and stress around stressful events, better self-rated sleep, and modest relief of short-term pain when inhaled alongside usual care. At normal scent use risks appear low; nothing yet links it to longer life. (Full Review)

Protocol

Acute anxiety (inhalation)
2–3 drops, 10–30 minutes
On cotton or gauze about 10 cm from the nose before a stressor
Sleep (bedtime inhalation)
5 drops nightly
On a cloth beside the pillow for 30 nights
Concentration, competing values
About 1% at most for large areas
2% for aromatherapy in a menstrual pain trial; 3% in sweet almond oil for back massage
Time to effect
Calming and pain
5–30 minutes
After inhalation in trials
Sleep
3–30 nights
Self-rated sleep improvements measured
Sexual function
Weeks 4–8
Of oral use in trials

Benefits

Contraindications
  • People with known fragrance allergy (positive patch test to geraniol, citronellol, eugenol or fragrance mixes)
  • Infants and toddlers (skin products)
  • Pregnant or breastfeeding women (oral use)
  • Children (any ingestion)
Key Interactions
Theoretical (inferred from mechanism)
  • Sedative prescription drugs (diazepam, zolpidem)
  • Blood-pressure-lowering drugs (amlodipine, losartan)
  • Sedating over-the-counter antihistamines (diphenhydramine, doxylamine)
  • Calming supplements (valerian, melatonin)
  • CYP2B6 substrates (bupropion, efavirenz), relevant only to ingestion
  • Other methyleugenol-containing oils (basil, tarragon)
  • Other fragrance products (perfumes, scented cosmetics)

Risk & Side Effects

  • Low: Contact dermatitis and skin sensitization; Headache, nausea and nasal irritation
  • Speculative: Genotoxic and carcinogenic constituents; Blood and spleen effects in infants from skin products

Monitoring

Marker Target Why
Home blood pressure <130/80 mm Hg Safety check with blood-pressure drugs
Pittsburgh Sleep Quality Index (PSQI) Global score ≤5 Tracks sleep change
State anxiety score (STAI-State) No established target; track change from own baseline Tracks anxiety change
Forearm patch test No established target; record absence of redness, itching or blistering at 48 hours Safety check: a positive reaction stops skin use
Alanine aminotransferase (ALT), oral use only About 7–55 U/L Safety check: a rise stops oral use

Cadence: Baseline before starting; anxiety and sleep scores after 1 and 4 weeks of regular use, then every 3–6 months; blood pressure at 1 week when combining with blood-pressure drugs or sedatives; for oral use, liver enzymes after 8 weeks.

Qualitative Assessment

  • Calm under stress: Self-rated tension before procedures, exams or demanding meetings
  • Sleep onset and continuity: Time to fall asleep, night awakenings and morning restedness
  • Pain coping: Pain intensity and need for rescue pain medication during short-lived pain
  • Skin and airway comfort: Absence of rash, itching, sneezing, headache or nausea after sessions
  • Scent response: Whether the scent still feels pleasant and noticeable